BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 6976828)

  • 1. Selected applications of methotrexate alone and in combination in osteosarcoma.
    Pratt CB
    Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose methotrexate in osteogenic sarcoma.
    Jaffe N; Link MP; Cohen D; Traggis D; Frei E; Watts H; Beardsley GP; Abelson HT
    Natl Cancer Inst Monogr; 1981 Apr; (56):201-6. PubMed ID: 6975438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
    Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
    Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
    Rosen G; Huvos AG; Marcove R; Nirenberg A
    Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on the treatment of pulmonary metastatic osteosarcoma].
    Yamawaki S; Isu K; Ubayama Y; Nakasato T; Goto M; Ishii S; Sasaki T; Usui M; Yagi T
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):998-1005. PubMed ID: 6964046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose methotrexate used alone and in combination for measurable primary or metastatic osteosarcoma.
    Pratt CB; Howarth C; Ransom JL; Bowles D; Green AA; Kumar AP; Rivera G; Evans WE
    Cancer Treat Rep; 1980 Jan; 64(1):11-20. PubMed ID: 6966535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
    Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
    Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
    Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP;
    J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
    Boussen H; Mezzi F; Gamoudi A; Daldoul O; Ben Hamida H; Mezlini A; Khalfallah S; Karray S; Ben Romdhane K; Ben Ghachem M; Ben Abdallah M; Douik M; Saadi A; Ben Ayed F; Ben Hassine H
    Bull Cancer; 2000 Feb; 87(2):183-8. PubMed ID: 10705289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
    Kotz R; Leber H; Ramach W; Arbes H; Wolf A
    Wien Klin Wochenschr; 1977 Jul; 89(14):474-9. PubMed ID: 70889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteosarcoma: review of the past, impact on the future. The American experience.
    Jaffe N
    Cancer Treat Res; 2009; 152():239-62. PubMed ID: 20213394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy for osteosarcoma at the Singapore General Hospital.
    Khor TH; Chua EJ; Tan BC; Chia KB
    Singapore Med J; 1983 Apr; 24(2):95-8. PubMed ID: 6577611
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidrug chemotherapy in osteosarcoma.
    Sutow WW
    Clin Orthop Relat Res; 1980; (153):67-72. PubMed ID: 7004713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of surgical adjuvant chemotherapy in osteosarcoma].
    Yamawaki S; Isu K; Ubayama Y; Goto M; Kobayash M; Ishii S; Usui M; Yagi T; Sasaki T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1430-7. PubMed ID: 3496046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy for osteosarcoma.
    Pratt CB; Rivera G; Shanks E; Kumar AP; Green AA; George S
    Cancer Treat Rep; 1978 Feb; 62(2):251-7. PubMed ID: 346214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue.
    Henderson IC; Gelman R; Canellos GP; Frei E
    Cancer Treat Rep; 1981; 65 Suppl 1():67-75. PubMed ID: 6976832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy for osteogenic sarcoma.
    Etcubanas E; Wilbur JR
    Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
    Cohen IJ
    Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.